Air Liquide is a global leader in gases, technologies, and services for industry and healthcare. Present in 72 countries with 67,800 employees, our Group serves more than 4 million customers and patients worldwide. Oxygen, nitrogen, and hydrogen are essential small molecules crucial for life, matter, and energy, representing Air Liquide’s scientific focus and central to our operations since our inception in 1902. At Air Liquide, taking proactive steps today while preparing for the future is core to our strategy. Air Liquide Venture Capital (ALIAD) was set up in 2013 as the Air Liquide Group’s venture capital arm.